Compono Appoints New CEO
Compono, an investee company within the Deepbridge Technology Growth EIS portfolio, has appointed Trent Innes, former Managing Director of Xero Australia and Asia, as its new CEO, effective from May 2nd 2022.
Compono, an investee company within the Deepbridge Technology Growth EIS portfolio, has appointed Trent Innes, former Managing Director of Xero Australia and Asia, as its new CEO, effective from May 2nd 2022.
Touch Biometrix, an investee company within the Deepbridge Technology Growth EIS portfolio, has announced a successful Series B funding round, with plans to launch a FAP60 fingerprint biometric sensor as the first prodct utilising its thin transistor film (TFT) technology with 'active pixels'.
As of the 25th April 2022, Deepbridge Capital is proud to announce that it has deployed a record £31.5 million into early-stage technology and life sciences companies during the 2021/22 tax year, up from £29.4 million in 2020/21.
Sky Medical Technology Ltd., an investee company within the Deepbridge Technology Growth EIS portfolio, announced further U.S. Food and Drug Administration (FDA) 510(k) clearance to market the new (W3) geko™ device variant, for increasing microcirculatory blood flow in lower limb soft tissue of patients with venous insufficiency and/or ischemia.
RDVault, an investee company within the Deepbridge Life Sciences EIS portfolio, has won Tech Nation's fourth Rising Stars competition, which recognises the best early-stage technology scale-ups across the UK.
Wastefront, which is behind plans to build a £100m tyre recycling plant at The Port of Sunderland, has revealed a partnership with one of Deepbridge's Technology Growth EIS Companies, ENSO Tyres Limited.